Clinical Trials Arena on MSN10h
Orca Bio makes a splash as T-cell therapy cuts GvHD in blood cancer patientsOrca Bio’s T-cell immunotherapy candidate for blood cancers has more than doubled the number of patients surviving free of ...
Pharmaceutical Technology on MSN13h
AstraZeneca and Alteogen agree on ALT-B4 platform techAstraZeneca has entered an exclusive licence agreement with Alteogen involving the latter’s ALT-B4 platform technology.
The company plans to submit a Biologics Licence Application to the US Food and Drug Administration later in 2025 for its DMD ...
Pharmaceutical Technology on MSN11h
Health Canada approves Biogen’s Skyclarys for Friedreich’s ataxiaHealth Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ataxia (FA) in individuals aged 16 years and above.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback